(Q47877301)

6 February 2018

title

Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery (English)

1 reference

6 February 2018

Aarne Feldheiser

1 reference

6 February 2018

Claudia Spies

object named as

Claudia Spies

1 reference

6 February 2018

author name string

Joachim Erb

1 reference

6 February 2018

Torsten Beutlhauser

1 reference

6 February 2018

Birgit Schuster

1 reference

6 February 2018

Sascha Treskatsch

1 reference

6 February 2018

Herko Grubitzsch

1 reference

6 February 2018

publication date

29 April 2014

1 reference

6 February 2018

Journal of International Medical Research

published in

1 reference

6 February 2018

volume

1 reference

6 February 2018

issue

1 reference

6 February 2018

page(s)

750-764

1 reference

6 February 2018

Long-term outcome of survivors of prolonged intensive care treatment after cardiac surgery

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Three-year survival after four major post-cardiac operative complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Maximizing survival potential in very high risk cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

The cardioprotective effects of levosimendan: preclinical and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Assessing pain in critically ill sedated patients by using a behavioral pain scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

The Surviving Sepsis Campaign sepsis change bundles and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan in aortic valve surgery: cardiac performance and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan, a new inotropic and vasodilator agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Potential negative effects of epinephrine on carotid blood flow and ETCO2 during active compression-decompression CPR utilizing an impedance threshold device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Variation in use of peroperative inotropic support therapy in cardiac surgery: time for reflection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513516293

21 January 2018

Identifiers

DOI

10.1177/0300060513516293

1 reference

6 February 2018

1 reference

6 February 2018